Free Trial

National Research (NASDAQ:NRC) Share Price Passes Above Two Hundred Day Moving Average - Here's Why

National Research logo with Business Services background

Key Points

  • National Research Corporation shares have crossed above their 200-day moving average at $14.48, reaching a trading high of $15.71.
  • The company reported a quarterly earnings per share (EPS) of $0.28 and declared a quarterly dividend of $0.12 per share, reflecting a yield of 3.1%.
  • Institutional investors hold 47.26% of National Research's stock, with notable increases in positions by firms like PNC Financial Services and Nisa Investment Advisors.
  • Looking to export and analyze National Research data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

National Research Corporation (NASDAQ:NRC - Get Free Report) shares crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $14.48 and traded as high as $15.71. National Research shares last traded at $15.53, with a volume of 115,752 shares.

National Research Price Performance

The firm has a fifty day simple moving average of $15.45 and a 200 day simple moving average of $14.44. The company has a market capitalization of $348.76 million, a PE ratio of 20.15 and a beta of 0.44. The company has a debt-to-equity ratio of 3.61, a quick ratio of 0.54 and a current ratio of 0.70.

National Research (NASDAQ:NRC - Get Free Report) last announced its quarterly earnings results on Monday, July 28th. The company reported $0.28 earnings per share (EPS) for the quarter. National Research had a return on equity of 83.52% and a net margin of 12.78%. The business had revenue of $34.04 million for the quarter.

National Research Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 3.1%. The ex-dividend date is Friday, September 26th. National Research's payout ratio is presently 63.16%.

Institutional Trading of National Research

Hedge funds have recently modified their holdings of the stock. EverSource Wealth Advisors LLC raised its holdings in National Research by 9,535.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,638 shares of the company's stock worth $28,000 after purchasing an additional 1,621 shares during the period. Strs Ohio acquired a new position in National Research in the 1st quarter worth about $33,000. Raymond James Financial Inc. acquired a new position in National Research in the 2nd quarter worth about $34,000. PNC Financial Services Group Inc. raised its holdings in National Research by 1,072.5% in the 2nd quarter. PNC Financial Services Group Inc. now owns 2,087 shares of the company's stock worth $35,000 after purchasing an additional 1,909 shares during the period. Finally, Aviso Financial Inc. raised its holdings in National Research by 37.2% in the 1st quarter. Aviso Financial Inc. now owns 3,076 shares of the company's stock worth $39,000 after purchasing an additional 834 shares during the period. Hedge funds and other institutional investors own 47.26% of the company's stock.

National Research Company Profile

(Get Free Report)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.

Further Reading

Should You Invest $1,000 in National Research Right Now?

Before you consider National Research, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Research wasn't on the list.

While National Research currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Market’s Next Big Winners? Start Here
5 High Short Interest Stocks to Buy Before November
HUGE Upside Ahead: The Fastest Growing ETFs in the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines